Want to join the conversation?
In the Surgical Heart Valve Therapy product group, 1Q16 sales were up slightly over 1Q15 on an underlying basis. In the Critical Care product group, sales grew 9% on an underlying basis, driven by enhanced surgical recovery program, which recorded double-digit underlying sales growth across most regions.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?